Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

CPA1 Inhibitors

The chemical class of CPA1 Inhibitors encompasses a range of compounds designed to modulate the activity of Carboxypeptidase A1 (CPA1), an enzyme playing a crucial role in protein digestion. These inhibitors are characterized by their diverse modes of action, each aimed at interfering with the enzymatic function of CPA1. The design and study of CPA1 inhibitors are grounded in the understanding of the enzyme's structure and function, particularly its role in cleaving amino acids from the C-terminal of proteins and peptides. This group of inhibitors operates primarily by targeting the active site of CPA1, where they either compete with natural substrates for binding or alter the enzyme's conformation, thereby inhibiting its activity. Another subset of these inhibitors focuses on the zinc ion, a vital cofactor in the enzymatic process of CPA1. By chelating this metal ion, these inhibitors render the enzyme inactive, demonstrating the critical nature of metal ions in the function of metalloenzymes like CPA1.

The development of CPA1 inhibitors represents a significant stride in the field of enzyme inhibition and provides valuable insights into the regulation of proteolytic enzymes. By understanding the mechanisms through which these inhibitors act, researchers can explore the enzyme's role beyond its primary function in protein digestion. This includes studying the enzyme's structure-activity relationship, which is vital for elucidating how CPA1 recognizes and interacts with its substrates and inhibitors. Moreover, the study of CPA1 inhibitors contributes to the broader understanding of enzymatic regulation and inhibition. These inhibitors serve as crucial tools for probing the dynamics of enzymatic action and the interactions between enzymes and small molecules. In essence, the CPA1 inhibitors are not just about impeding an enzyme's function; they offer a window into the complex world of enzymatic processes and the potential to explore new aspects of biochemistry and molecular biology. Through these inhibitors, the nuanced mechanisms of enzyme action can be unraveled, offering a deeper understanding of how enzymes are regulated and how they can be modulated for various purposes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

1,10-Phenanthroline

66-71-7sc-255888
sc-255888A
2.5 g
5 g
$23.00
$32.00
(0)

Might inhibit CPA1 by directly removing its essential zinc cofactor.

Gabexate mesylate

56974-61-9sc-215066
5 mg
$100.00
(0)

Might inhibit CPA1 directly by interfering with its protease activity.

Aphidicolin

38966-21-1sc-201535
sc-201535A
sc-201535B
1 mg
5 mg
25 mg
$84.00
$306.00
$1104.00
30
(3)

Could inhibit CPA1 by directly affecting its protease activity.

Bestatin

58970-76-6sc-202975
10 mg
$131.00
19
(3)

Known as an aminopeptidase inhibitor, could directly inhibit CPA1.

E-64

66701-25-5sc-201276
sc-201276A
sc-201276B
5 mg
25 mg
250 mg
$281.00
$947.00
$1574.00
14
(0)

Could inhibit CPA1 by directly impacting its enzymatic activity.

Leupeptin hemisulfate

103476-89-7sc-295358
sc-295358A
sc-295358D
sc-295358E
sc-295358B
sc-295358C
5 mg
25 mg
50 mg
100 mg
500 mg
10 mg
$73.00
$148.00
$316.00
$499.00
$1427.00
$101.00
19
(3)

Might inhibit CPA1 by directly interfering with its protease function.

Aprotinin

9087-70-1sc-3595
sc-3595A
sc-3595B
10 mg
100 mg
1 g
$112.00
$408.00
$3000.00
51
(2)

A broad-spectrum protease inhibitor that could directly inhibit CPA1.

Benzamidine

618-39-3sc-233933
10 g
$292.00
1
(0)

Could possibly inhibit CPA1 as a serine protease inhibitor.

AEBSF hydrochloride

30827-99-7sc-202041
sc-202041A
sc-202041B
sc-202041C
sc-202041D
sc-202041E
50 mg
100 mg
5 g
10 g
25 g
100 g
$65.00
$122.00
$428.00
$851.00
$1873.00
$4994.00
33
(1)

Might inhibit CPA1 directly as a serine protease inhibitor.